首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1701459

醫學影像試劑市場規模、佔有率、成長分析（按類別、按方式、按技術、按應用、按地區）－2025 年至 2032 年產業預測

Medical Imaging Reagents Market Size, Share, and Growth Analysis, By Class (Contrast reagents, Optical reagents), By Modality (X-ray, CT Scan), By Technology, By Application, By Region - Industry Forecast 2025-2032

出版日期: 2025年04月03日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023 年醫學影像試劑市場規模價值為 173.5 億美元，預計將從 2024 年的 182.5 億美元成長到 2032 年的 273.8 億美元，預測期內（2025-2032 年）的複合年成長率為 5.2%。

全球科學成像試劑市場是醫療保健的重要組成部分，為診斷和研究提供必要的工具。這些藥劑增強了 MRI、CT、超音波和核子醫學等醫學影像方式中組織和器官的可見性。主要的市場促進因素包括慢性病盛行率上升、人口老化以及對準確和早期診斷的需求不斷增加。因此，醫學影像試劑可以顯著提高診斷準確性和治療計劃，改善患者的治療效果。最近的趨勢集中在提供詳細功能和代謝資訊的分子成像技術，增加了對可以針對特定分子的先進試劑的需求。此外，混合成像系統的興起使得需要能夠適應多種模式的多功能試劑。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業市場定位（2024年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2024年）
主要企業簡介
- 公司詳情
- 產品系列分析
- 公司分部佔有率分析
- 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

GE Healthcare（USA）
Siemens Healthineers（Germany）
Bracco Imaging SpA（Italy）
Bayer AG（Germany）
Guerbet Group（France）
Lantheus Holdings Inc.（USA）
Jubilant Radiopharma（India）
Cardinal Health Inc.（USA）
Nordion（Canada）Inc.（Canada）
Curium Pharma（France）
Advanced Accelerator Applications（AAA）-A Novartis Company（Switzerland）
Eli Lilly and Company（USA）
Thermo Fisher Scientific Inc.（USA）
PerkinElmer Inc.（USA）
Agfa-Gevaert Group（Belgium）
Merck KGaA（Germany）
Triad Isotopes Inc.（USA）
Nihon Medi-Physics Co. Ltd.（Japan）
Shenzhen Mindray Bio-Medical Electronics Co. Ltd.（China）
EczacIbasI-Monrol Nuclear Products（Turkey）

結論和建議

簡介目錄

Product Code: SQMIG35A2744

Medical Imaging Reagents Market size was valued at USD 17.35 billion in 2023 and is poised to grow from USD 18.25 billion in 2024 to USD 27.38 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global scientific imaging reagents market is a vital component of the healthcare landscape, providing essential tools for diagnostics and research. These reagents enhance the visibility of tissues and organs in medical imaging modalities like MRI, CT, ultrasound, and nuclear medicine. Key market drivers include the rising incidence of chronic illnesses, an aging population, and the increasing need for precise early diagnosis. As a result, medical imaging reagents significantly enhance diagnostic accuracy and treatment planning, improving patient outcomes. Recent trends indicate a growing focus on molecular imaging techniques that offer detailed functional and metabolic information, driving demand for advanced reagents targeting specific molecules. Ongoing R&D efforts aim to create safer, more efficient reagents, while the rise of hybrid imaging systems necessitates versatile reagents adaptable to multiple modalities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Imaging Reagents Market Segments Analysis

Global Medical Imaging Reagents Market is segmented by Class, Modality, Technology, Application and region. Based on Class, the market is segmented into Contrast reagents, Optical reagents and Nuclear reagents. Based on Modality, the market is segmented into X-ray, CT Scan, Ultrasound and MRI Scan. Based on Technology, the market is segmented into Nanoparticles, Fluorescent dyes & probes, Radiopharmaceuticals, Fluorescent proteins and Quantum dots. Based on Application, the market is segmented into Diagnostics, Drug discovery & development and Educational Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Medical Imaging Reagents Market

The rising incidence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions has led to an escalating demand for medical imaging procedures. This growing healthcare need places significant importance on medical imaging reagents, which enhance the precision and efficacy of diagnostic imaging techniques. Consequently, their crucial role in facilitating accurate diagnoses is driving increased adoption across healthcare facilities. As the healthcare sector continues to evolve and adapt to the growing prevalence of these health issues, the demand for reliable medical imaging reagents is expected to surge, further supporting advancements in diagnostic technologies and ultimately improving patient outcomes.

Restraints in the Medical Imaging Reagents Market

The Medical Imaging Reagents market faces significant restraints, particularly due to the high costs associated with advanced imaging techniques such as PET and MRI. These expenses not only encompass the reagents themselves but also the necessary equipment and related healthcare services, creating a substantial financial burden for both healthcare facilities and patients. This pricing challenge can hinder market growth, particularly in economically disadvantaged regions where access to such advanced imaging technologies is limited. Consequently, the affordability and overall economic dynamics of the healthcare system are crucial factors influencing the uptake and expansion of medical imaging reagents in various markets.

Market Trends of the Medical Imaging Reagents Market

The Medical Imaging Reagents market is witnessing a robust trend driven by the surging demand for molecular imaging agents, particularly positron emission tomography (PET) and single-photon emission computed tomography (SPECT) radiopharmaceuticals. These innovative reagents facilitate precise visualization and quantification of biological processes at the molecular and cellular levels, proving essential for early disease detection, treatment planning, and monitoring. Significant advancements in the development of radiopharmaceuticals-focused on enhancing specificity and targeting-are further propelling this demand. This trend underscores the healthcare sector's shift towards personalized medicine, with molecular imaging playing a pivotal role in diagnosing and managing complex diseases effectively.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis

Global Medical Imaging Reagents Market Size by Class & CAGR (2025-2032)

Market Overview
Contrast reagents
Optical reagents
Nuclear reagents

Global Medical Imaging Reagents Market Size by Modality & CAGR (2025-2032)

Market Overview
X-ray
CT Scan
Ultrasound
MRI Scan

Global Medical Imaging Reagents Market Size by Technology & CAGR (2025-2032)

Market Overview
Nanoparticles
Fluorescent dyes & probes
Radiopharmaceuticals
Fluorescent proteins
Quantum dots

Global Medical Imaging Reagents Market Size by Application & CAGR (2025-2032)

Market Overview
Diagnostics
Drug discovery & development
Educational Research

Global Medical Imaging Reagents Market Size & CAGR (2025-2032)

North America (Class, Modality, Technology, Application)
- US
- Canada
Europe (Class, Modality, Technology, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Class, Modality, Technology, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Class, Modality, Technology, Application)
- Brazil
- Rest of Latin America
Middle East & Africa (Class, Modality, Technology, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guerbet Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lantheus Holdings Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jubilant Radiopharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nordion (Canada) Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curium Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advanced Accelerator Applications (AAA) - A Novartis Company (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agfa-Gevaert Group (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Triad Isotopes Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Medi-Physics Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EczacIbasI-Monrol Nuclear Products (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments